CLEARPOINT NEURO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.58 USD | -0.53% |
|
-12.54% | -17.82% |
| Mar. 13 | Stifel Adjusts Price Target on ClearPoint Neuro to $9 From $8, Maintains Buy Rating | MT |
| Mar. 12 | ClearPoint Neuro, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Presentation Operator MessageOperator (Operator)Greetings, and welcome to the ClearPoint Neuro...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Companyâs flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. It also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.
Calendar
2024-05-07
- Q1 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5.61
USD
Average target price
10
USD
Spread / Average Target
+78.25%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -17.82% | 152M | |
| +4.48% | 213B | |
| +3.89% | 177B | |
| +12.21% | 134B | |
| +17.83% | 99.13B | |
| +0.11% | 63.47B | |
| +18.10% | 53.69B | |
| -4.51% | 46.36B | |
| -1.60% | 41.09B | |
| +11.07% | 39.3B |
- Stock Market
- Equities
- CLPT Stock
- News ClearPoint Neuro, Inc.
- Transcript : ClearPoint Neuro, Inc., Q3 2021 Earnings Call, Nov 09, 2021
